Name:Jinan KangHe Pharmaceutical Technology Co., Ltd

Category:Corporation/Limited Liability Company

Trade Category: Manufacturer

Legal Representative:

Employees:101 - 500 People

Address:No. 2766 Ying Xiu Road, Jinan High-tech industries development zone, Shandong province,P.R. China

Website:http://www.kanghe-pharma.com

Product/Service:Desmopressin,Thymalfasin,Liraglutide. Eptibatide,Terlipressin,Bivalirudin.Argireline,L-Carnosine.COPPER-GU, Palmitoyl Pentapeptide-3,Palmitoyl Tripeptide-5,PalMitoyl Tripeptide-1,Nonapeptide-1

Jinan KangHe Pharmaceutical Technology Co., Ltd is the subsidiary company of AoHe pharmaceutical group that combine R&D ,Production and Market sale as one of the innovative high-tech pharmaceutical enterprise, including subsidiary:

Jinan KangHe Pharmaceutical Technology Co., Ltd( R&D center-Jinan)

Shandong Lusheng Pharmaceutical Co., Ltd(Production Base-Dezhou）

AoHe pharmaceutical(Beijing) group( Marketing Center- Beijing)

Jinan KangHe Pharmaceutical Technology Co., Ltd was founded in 2011, located in Jinan High-tech Park 5150 high-level personnel new drug R&D base, and it focuses on the development of New Drug, registration and declaration. The main business cover R&D, production and sales of peptide, chemical and biological APIs and drug product as well as peptide for custom design, beauty peptide, peptide APIs, pharmaceutical intermediates processing and so on.

KangHe  has a strong R&D team, employed more than 200 research staffs, including graduate students graduated from key universities accounted for more than 65%, in addition, KangHe  is creating a post-doctoral workstations. In order to ensure leading technology, KangHe  also hired the first-class domestic medical experts as technical counselor.

KangHe  invested 320 million to build its production base according to the cGMP specification at national biology high-tech industrial park at Dezhou city in Shandong province. Wherein the Peptide APIs workshop conform to cGMP standards according to America and Europe registeration and  certification . With the supply capacity of peptide APIs from grams to kilograms.

KangHe has been adhering to the concept of "Health to the people, Harmony to the success". Focusing on R&D of new drug, following the world new drug development direction, forming a highly efficient system on the NDA and ANDA.